Risperidone for the treatment of behavioral disturbances in dementia: A case series

Journal of Neuropsychiatry and Clinical Neurosciences

Volumn 10, Issue 2, 1998, Pages 220-223

  Herrmann, Nathan ^a   Rivard, Marie France ^b   Flynn, Michael ^b   Ward, Carol ^b   Rabheru, Kiran ^b   Campbell, Barry ^b  

^a SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

RISPERIDONE;

AGED; AGGRESSION; AGITATION; ARTICLE; BEHAVIOR DISORDER; CLINICAL ARTICLE; DELUSION; DEMENTIA; DRUG EFFICACY; EXTRAPYRAMIDAL SYMPTOM; FALLING; FEMALE; HALLUCINATION; HUMAN; LETHARGY; MALE; PRIORITY JOURNAL; RIGIDITY; SEDATION;

EID: 0031799624     PISSN: 08950172     EISSN: None     Source Type: Journal    
DOI: 10.1176/jnp.10.2.220     Document Type: Article

References (15)

1. Herrmann N, Lanctôt KL, Naranjo CA: Behavioral disorders in demented elderly patients: current issues in pharmacotherapy. CNS Drugs 1996; 6:280-300
2. McKeith IG, Galasko D, Kosaka K, et al: Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB). Neurology 1996; 47:1113-1124
3. Guy W: ECDEU Assessment Manual for Psychopharmacology (DHEW Publ No ADM 76-338). Rockville, MD, National Institute of Mental Health, 1976, pp 218-222
4. Reisberg B, Ferris SH, de Leon MJ, et al: The Global Deterioration Scale for assessment of primary degenerative dementia. Am J Psychiatry 1982; 139:1136-1139
5. Folstein MF, Folstein SE, McHugh PR: "Mini-Mental State": a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12:189-198
6. Schneider LS, Pollock VE, Lyness SA: A meta-analysis of controlled trials of neuroleptic treatment in dementia. J Am Geriatr Soc 1990; 38:553-563
7. Madhusoodanan S, Brenner R, Araujo L, et al: Efficacy of risperidone treatment for psychoses associated with schizophrenia, schizoaffective disorder, bipolar disorder, or senile dementia in 11 geriatric patients: a case series. J Clin Psychiatry 1995; 56:514-518
8. Mertens C, Heylen SL: Risperidone in psychogeriatric patients with behavioral disturbances: an open long-term follow-up study. Report for trial RIS-BEL-13. Janssen Research Foundation, 1990 (data on file)
9. Lee H, Cooney JM, Lawlor BA: The use of risperidone, an atypical neuroleptic, in Lewy body disease. Int J Geriatr Psychiatry 1994; 9:415-417
10. Allen RL, Walker Z, D'Ath PJ, et al: Risperidone for psychotic and behavioral symptoms in Lewy body dementia (letter). Lancet 1995; 346:185
11. Rich SS, Friedman JH, Ott BR: Risperidone versus clozapine in the treatment of psychosis in six patients with Parkinson's disease and other akinetic-rigid syndromes. J Clin Psychiatry 1995; 56:556-559
12. Meco G, Alessandria A, Bonifati V, et al: Risperidone for hallucinations in levodopa-treated Parkinson's disease patients. Lancet 1994; 343:1370-1371
13. Jeste DV, Eastham JH, Lacro JP, et al: Management of late-life psychosis. J Clin Psychiatry 1996; 57(suppl 3):39-45
14. Sunderland T, Tariot PN, Cohen RM, et al: Anticholinergic sensitivity in patients with dementia of the Alzheimer type and age-matched controls: a dose-response study. Arch Gen Psychiatry 1987; 44:418-426
15. Richelson E: Preclinical pharmacology of neuroleptics: focus on new generation compounds. J Clin Psychiatry 1996; 57(suppl 11):4-11